At present more than 250 million of population suffering from diabetes in world . Diabetes patient is going to increase & figure is projected to rise up to 380 million by 2025, largely due to population growth, aging, urbanization, unhealthy eating habits, increased body fat and a sedentary lifestyle. By 2025, the number of people with diabetes is expected to more than double in South-East Asia, the Eastern Mediterranean and Middle East, and Africa.

BioClinAarc has experience in conducting endocrinology trial studies & providing entire services required to conduct respiratory clinical trial.

We have complete solution according to client's project requirement. ClinAarc provide entire services for endocrinology trials includes medical writing, regulatory activities, Clinical trial operations, drug safety, data management & biostatistics.

We help you with a systematic planning, adequate infrastructure, time bound consistent quality execution, qualified & experience investigator and project team members in every phase of trial, from phase I to post-marketing i.e. phase IV (including PK/PD and Biomarkers) studies with ease.